BioSpace News Archive

Takeda Pharmaceutical has come back to the bargaining table with a juicier bid for Shire. Yesterday, Takeda’s $60 billion-plus bid for Shire took an odd turn late yesterday when Dublin, Ireland-based Allergan was reported to be in talks with Shire as well. However, by the end of the day, Allergan had stated that it “does not intend to make an offer for Shire.”

A pioneer in CAR-T therapies has been named one of Time Magazine’s 100 most influential people in the world for 2018.

Plenty of exciting news in the research world. Here’s a look at some of the top stories.

Bluebird bio announced interim data from two different two-year clinical trials of LentiGlobin gene therapy for transfusion-dependent beta-thalassemia (TDT).

Shares of Ionis Pharmaceuticals are up more than 10 percent in premarket trading after Biogen handed over $1 billion to support a new 10-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases.

It’s no secret that China has become an ever-increasing important component for drug development. Not only is the country seen as a lucrative market for drugs, entities within the country are making heavy investments in the global biotech industry.

The U.S. Food and Drug Administration (FDA)’s Peripheral and Central Nervous System Drugs Advisory Committee unanimously recommended the approval of London, UK-based GW Pharmaceuticals’ Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome.

Novartis released new information that showed siponimod consistently reduced the risk of confirmed disability progression in secondary progressive multiple sclerosis (SPMS) patients.

Novel point-of-care test to assess risk of spontaneous preterm birth, reducing unnecessary hospital admissions and safeguarding babies

The Chan Zuckerberg Initiative, a donor-advised fund of Silicon Valley Community Foundation, is funding 85 projects, including three at UC Santa Cruz, to support efforts to develop a comprehensive reference atlas of all cells in the human body